Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific open surgery instrument market was negatively impacted by the COVID-19 pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. However, the market has been recovering strongly and will exhibit moderate growth over the forecast period, fueled mainly by an expanding patient pool, attributable to an aging population and rising disease prevalence, and thus rising procedure volumes.

This Medtech 360 Report provides high-level market metrics for open surgery instruments in Asia Pacific, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2031.

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…